Voyager Therapeutics, Inc. (31) | License Agreements (4)
Recent Contracts
-
Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022
(Filed With SEC on May 4, 2022)
-
Option and License Agreement, by and between the Registrant and Pfizer Inc., dated October 1, 2021
(Filed With SEC on November 2, 2021)
-
First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020
(Filed With SEC on November 9, 2020)
-
Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019
(Filed With SEC on August 9, 2019)